Anupam Rama

Stock Analyst at JP Morgan

(3.37)
# 913
Out of 4,893 analysts
262
Total ratings
42.33%
Success rate
4.79%
Average return

Stocks Rated by Anupam Rama

Sarepta Therapeutics
Jul 10, 2025
Maintains: Overweight
Price Target: $30$28
Current: $19.01
Upside: +47.29%
Cogent Biosciences
Jul 10, 2025
Maintains: Overweight
Price Target: $25$29
Current: $10.86
Upside: +167.03%
IDEAYA Biosciences
May 22, 2025
Maintains: Overweight
Price Target: $63$66
Current: $22.80
Upside: +189.47%
Olema Pharmaceuticals
Mar 28, 2025
Maintains: Overweight
Price Target: $30$28
Current: $4.87
Upside: +474.95%
Ultragenyx Pharmaceutical
Mar 27, 2025
Maintains: Overweight
Price Target: $104$117
Current: $31.13
Upside: +275.84%
Neurocrine Biosciences
Mar 26, 2025
Maintains: Overweight
Price Target: $183$184
Current: $134.93
Upside: +36.37%
BridgeBio Pharma
Mar 24, 2025
Maintains: Overweight
Price Target: $44$50
Current: $46.32
Upside: +7.96%
Syndax Pharmaceuticals
Mar 20, 2025
Maintains: Overweight
Price Target: $39$41
Current: $9.81
Upside: +317.94%
Zai Lab
Mar 13, 2025
Maintains: Overweight
Price Target: $44$51
Current: $34.09
Upside: +49.60%
Solid Biosciences
Mar 13, 2025
Maintains: Overweight
Price Target: $12$11
Current: $5.44
Upside: +102.21%
Maintains: Overweight
Price Target: $39$34
Current: $7.19
Upside: +372.88%
Maintains: Overweight
Price Target: $36$42
Current: $26.13
Upside: +60.73%
Maintains: Overweight
Price Target: $77$71
Current: $24.34
Upside: +191.70%
Maintains: Overweight
Price Target: $50$54
Current: $19.55
Upside: +176.29%
Maintains: Overweight
Price Target: $42$44
Current: $16.49
Upside: +166.83%
Maintains: Overweight
Price Target: $16$18
Current: $10.83
Upside: +66.28%
Maintains: Overweight
Price Target: $21$22
Current: $11.44
Upside: +92.31%
Initiates: Overweight
Price Target: $30
Current: $15.61
Upside: +92.18%
Maintains: Overweight
Price Target: $16$17
Current: $6.31
Upside: +169.63%
Downgrades: Underweight
Price Target: n/a
Current: $8.67
Upside: -
Maintains: Overweight
Price Target: $39$40
Current: $28.94
Upside: +38.22%
Maintains: Overweight
Price Target: $100$125
Current: $81.98
Upside: +52.48%
Initiates: Neutral
Price Target: n/a
Current: $5.24
Upside: -
Maintains: Neutral
Price Target: $12$10
Current: $9.20
Upside: +8.70%
Downgrades: Neutral
Price Target: n/a
Current: $0.40
Upside: -
Upgrades: Neutral
Price Target: n/a
Current: $2.62
Upside: -
Maintains: Overweight
Price Target: $11$13
Current: $2.80
Upside: +365.12%
Maintains: Neutral
Price Target: $8$9
Current: $0.37
Upside: +2,331.78%
Downgrades: Underweight
Price Target: n/a
Current: $4.48
Upside: -
Downgrades: Underweight
Price Target: n/a
Current: $0.38
Upside: -
Downgrades: Neutral
Price Target: $250
Current: $9.54
Upside: +2,521.92%
Downgrades: Neutral
Price Target: n/a
Current: $0.39
Upside: -
Initiates: Overweight
Price Target: $58
Current: $36.67
Upside: +58.17%
Upgrades: Neutral
Price Target: $7$12
Current: $11.47
Upside: +4.62%
Upgrades: Neutral
Price Target: $29$37
Current: $5.98
Upside: +518.73%
Upgrades: Overweight
Price Target: $55
Current: $52.78
Upside: +4.21%
Initiates: Overweight
Price Target: $28
Current: $1.53
Upside: +1,736.07%
Downgrades: Neutral
Price Target: $54
Current: $39.68
Upside: +36.09%
Initiates: Overweight
Price Target: $45
Current: $0.38
Upside: +11,649.35%
Initiates: Overweight
Price Target: $27
Current: $8.80
Upside: +206.99%
Initiates: Overweight
Price Target: $40
Current: $10.23
Upside: +291.20%
Downgrades: Neutral
Price Target: $133$137
Current: $322.30
Upside: -57.49%
Initiates: Overweight
Price Target: $39
Current: $4.53
Upside: +760.93%
Downgrades: Neutral
Price Target: $29$48
Current: $7.64
Upside: +528.27%
Upgrades: Overweight
Price Target: n/a
Current: $10.90
Upside: -
Maintains: Overweight
Price Target: $15$18
Current: $0.88
Upside: +1,945.45%
Initiates: Overweight
Price Target: $30
Current: $0.91
Upside: +3,214.55%
Upgrades: Neutral
Price Target: n/a
Current: $49.51
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $0.78
Upside: -